Real World Data Project: T1D Total Daily Insulin Dose
The Daily Insulin Dose Real World Data Project aim was to estimate total daily insulin dose in children and adolescents with T1D. This project was sponsored by Vertex Pharmaceuticals and will be presented at the upcoming EASD 2024 conference.
The study population included:
A total of 14,358 individuals were included (mean [SD] age: 16.2 [4.3] years; 48.0% female; 74.6% white; 58.3% private insurance).
Study population had a mean (SD) T1D duration of 7.8 (4.2) years, duration of follow-up of 4.9 (2.7) years and with 3.6 (2.9) endo visits per year.
Findings from this study showed that:
TDD increased by age and reached a peak that coincided with expected pubertal timing, earlier for females vs. males.
MDI users had higher TDD than pump users, which may reflect the impact of technology on dose.
Higher TDD was observed among those with higher BMI.
The T1DX-QI Best Practice Advisory Equity Project (BPA-TECH) aims to standardize a process and equitable approach for prescribing Advanced Diabetes Technologies (ADTs) for people living with T1D. The BPA will be integrated into each center’s Electronic Health Record to improve rate of ADT prescription.
The Project PI's include Osagie Ebekozien, MD, MPH, Nestoras Mathioudakis, MD, MHS and Risa Wolf, MD. This project launched Q2 2024 and is sponsored by Breakthrough T1D.
There are eight participating centers:
1. Seattle Children’s Hospital (PI: Meenal Gupta, MD) 2. Hassenfeld Children’s Hospital (PI: Mary Pat Gallagher, MD) 3.Grady Memorial Hospital (PI: Georgia Davis, MD) 4.SUNY Upstate Diabetes Center (PI: Ruth Weinstock, MD, PhD) 5. Nationwide Children’s Hospital (PI: Manmohan Kamboj, MD) 6. UT Southwestern Children's Hospital (PI: Abha Choudhary, MD)
T1DX-QI Learning Session 2024 Registration is Still Open!
The T1DX-QI November Learning Session will be held Monday, November 11, in Chicago, IL. The Learning Session will be a 1 day event this year.
Please use this link to view the FAQ. Please view these details before registering and use this link to register. Registration closes October 31, 2024.
ADEPT 2024 Registration is Still Open!
We are very excited to share that T1D Exchange in collaboration with American Diabetes Association (ADA) will be hosting a new diabetes equity focused conference titled Achieving Diabetes Equity Practice Today (ADEPT). ADEPT 2024 will be held Tuesday and Wednesday, November 12-13 following the T1DX-QI Learning Session 2024 in Chicago, IL.
The conference objectives are to highlight equity best practices and practical strategies on all areas of diabetes, (prediabetes, type 1, type 2, gestational diabetes, and diabetes in pregnancy). We encourage members to attend and invite your colleagues.
Use this link to view the FAQ. Please view these details before registering and use this link to register.
For additional questions please email qi@t1dexchange.org. Registration closes October 31, 2024.
T1DX-QI Portal Plot
The T1DX-QI Portal library has been updated to allow users to view articles in a more dynamic search.
Search by keywords, dates, categories, center type, and center name for more dynamic search under browse collections.
Recommended resources are user specific curated from Improve tab projects
My favorites creates a personalized library of a user’s most liked resources
Browse collections allows a user to view all library articles, which can be tailored by top rated, date uploaded, a-z, and most viewed.
T1DX-QI will be represented by 2 oral presentations at the 60th annual EASD Conference September 9-13, 2024.
Title: Association of CGM use with glycemic outcomes for people with type 2 diabetes: a multi-center observational longitudinal study
Presenters: Osagie Ebekozien, Ann Mungmode, Ori Odugbesan, Marina Basina, Sandra Tsai, Ruth Weinstock.
*Sponsored by Abbott Diabetes
Title: Real-world Total Daily Insulin Dose in 14,358 Young Individuals With Type 1 Diabetes in the US: Data From the T1D Exchange Quality Improvement Collaborative
Presenters: Osagie Ebekozien, Saketh Rompicherla, Selorm Dei-Tutu, Justin A. Indyk, Janine Sanchez, Allison Mekhoubad, Meredith Wilkes, Rachel Bhak, Dayna McGill, Tina Gupta, Yumin Zhang, Jason Gaglia
*Sponsored by Vertex Pharmaceuticals
Use this link to view all T1DX-QI publications and abstracts.
T1DX-QI 2024 Publications
We are excited to share that T1DX-QI now has published 25 manuscripts in 2024. Our most recent articles are now live online. You can view all T1DX-QI publications and abstracts using this link.
Title: Increasing Access to Connected Insulin Pens by Promoting Shared Decision-Making Through Collaborative Quality Improvement
Authors: Jared Friedman, Ori Odugbesan, Osagie Ebekozien, Grazia Aleppo
There have been several newly asked questions on the internal member website. Please use this link to respond and see all questions.
New Questions:
Question:
Is anyone tracking the number of patients that order pumps but do not start them? If so, would you mind sharing what you’ve found? We are hoping to improve upon this at our clinic and catch those who got lost in the process, but are curious if there seems to be a general non-starter rate around all of the clinics.
Hi All, Does anyone have a patient handout or education material that goes over insulin pump troubleshooting when patients start new pumps? I found some information through ADCES, but curious what you all see at your sites that you would find helpful to have on an insulin pump troubleshooting handout. Thanks!
Mineola, Long Island, NY – NYU Langone Health, NYU Langone Hospital—Long Island, Department of Pediatrics, Division of Endocrinology is seeking a middle-level candidate for a fulltime faculty position, with a minimum of 5+ years of experience, to join its existing department. Candidates will have earned a D.O., M.D., or equivalent and be Board Certified or Board Eligible in Endocrinology. Position available January 2025. Please use this link to view more details.
The T1DX-QI Annual Center survey has been shared with PI's and Coordinators. Please submit responses by October 4, 2024.
The Icahn School of Medicine at Mount Sinai is hosting their Twenty-third Annual Pediatric Endocrinology and Diabetes Symposium on Monday November 11, 2024. Please use this link to view conference details. T1DX-QI members can use code (24T1D) for 50% off registration.
Children with Diabetes is hosting three dinner events in Dallas, Los Angeles, and New York. Please use this link to view more details.
Upcoming Committee Calls
Please email qi@t1dexchange.org if you would like to receive the invite for any of the upcoming committee calls.
T2D Pediatric Working Group: September 13, 11-12pm EST
.png?upscale=true&width=520&upscale=true&name=MicrosoftTeams-image%20(58).png)